FIELD NOTES
Research notes, product guides, and insights from the Lakeshore Peptides team.
Aug 07, 2026
Heavy alcohol use harms metabolic health. A trial testing tirzepatide for alcohol reduction raises the question: could adding the peptide...
Read articleAug 05, 2026
When insurers deny coverage for tirzepatide or semaglutide, AOD-9604 emerges as a research peptide with a distinct fat-loss mechanism. This...
Read articleJul 31, 2026
Tirzepatide withdrawal often triggers weight regain as mitochondrial adaptations fade. A MOTS-c bridge strategy may preserve metabolic memory, but
Read articleJul 29, 2026
The FDA panel vote on tirzepatide sparks a prescribing boom, but metabolic science reveals gaps between approved drugs and unregulated...
Read articleJul 24, 2026
Tirzepatide and other weight loss peptides may cause menstrual irregularities. This article reviews the limited research on cycle disruption, comparing
Read articleJul 22, 2026
AOD-9604 and tirzepatide target fat loss through different mechanisms, but no studies support their combined use. Regulatory gaps and safety...
Read article